RSSRosacea

A Novel Night Moisturizer Enhances Cutaneous Barrier Function in Dry Skin and Improves Dermatological Outcomes in Rosacea-prone Skin

A Novel Night Moisturizer Enhances Cutaneous Barrier Function in Dry Skin and Improves Dermatological Outcomes in Rosacea-prone Skin

| December 1, 2018

J Clin Aesthet Dermatol. 2018;11(12):11–17 by Francine Santoro, MD, and Sandrine Teissedre, MSc Dr. Santoro is with Galderma Research and Development in Egerkingen, Switzerland. Dr. Teissedre is with Galderma Research and Development in Sophia Antipolis, France. FUNDING: This study was funded by Galderma Spirig. Medical writing and editorial support, provided by Mark Greener on behalf […]

Continue Reading

Quality of Life in Individuals with Erythematotelangiectatic and Papulopustular Rosacea: Findings From a Web-based Survey

Quality of Life in Individuals with Erythematotelangiectatic and Papulopustular Rosacea: Findings From a Web-based Survey

| February 1, 2018

by Joshua A. Zeichner, MD; Lawrence F. Eichenfield, MD; Steven R. Feldman, MD, PhD; J. Scott Kasteler, MD; and Ilia L. Ferrusi, PhD Dr. Zeichner is with Mount Sinai Hospital in New York, New York. Dr. Eichenfield is with the University of California and Rady Children’s Hospital, both in San Diego, California. Dr. Feldman is with […]

Continue Reading

Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea

Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea

| September 1, 2017

by James Q. Del Rosso, DO, FAOCD, FAAD Dr. Del Rosso is Research Director at JDR Dermatology Research in Las Vegas, Nevada; Adjunct Clinical Professor of Dermatology at Touro University Nevada, Las Vegas; and with Dermatology and Cutaneous Surgery at Thomas Dermatology in Las Vegas, Nevada. Funding: The author did not receive any form of […]

Continue Reading

Topical Alpha-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?

Topical Alpha-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?

| July 1, 2017

by James Q. Del Rosso, DO, FAOCD, FAAD Dr. Del Rosso is Research Director at JDR Dermatology Research, Las Vegas, Nevada and at Henderson Dermatology Research in Henderson, Nevada; is Adjunct Clinical Professor (Dermatology) at ableouro University Nevada, Las Vegas, Nevada; and practices Dermatology and Cutaneous Surgery at Thomas Dermatology in Las Vegas, Nevada. J […]

Continue Reading

The Burden of Illness of Erythematotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey

The Burden of Illness of Erythematotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey

| June 1, 2017

aJames Q. Del Rosso, DO, FAOCD, FAAD; bEmil A. Tanghetti, MD; cHilary E. Baldwin, MD; dDavid A. Rodriguez, MD; eIlia L. Ferrusi, PhD aJDR Dermatology Research/Thomas Dermatology, Las Vegas, Nevada bThe Center for Dermatology and Laser Surgery, Sacramento, California cThe Acne Treatment and Research Center, Morristown, New Jersey dDermatology Associates and Research, Coral Gables, Florida; […]

Continue Reading

Rosacea, Reactive Oxygen Species, and Azelaic Acid

Rosacea, Reactive Oxygen Species, and Azelaic Acid

| January 23, 2009 | 0 Comments

by David A. Jones, MD, PhD Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts Abstract Rosacea is a common skin condition thought to be primarily an inflammatory disorder. Neutrophils, in particular, have been implicated in the inflammation associated with rosacea and mediate many of their effects through the release of reactive oxygen species. Recently, […]

Continue Reading

The Role of Diet in Acne and Rosacea

The Role of Diet in Acne and Rosacea

| September 16, 2008 | 0 Comments

by Jonette E. Keri, MD, PhD, and Adena E. Rosenblatt Department of Dermatology, University of Miami Miller School of Medicine, Miami, Florida Disclosure: The authors identified no conflicts of interest.

Continue Reading